Health Professional Radio - Podcast
FDA Approves Seqirus™ FLUAD® QUADRIVALENT For Adults Over 65
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:09:02
- Mas informaciones
Informações:
Sinopsis
Returning guest, Dr. Gregg Sylvester, Chief Medical Officer at Seqirus discusses the background on the new formulation of FLUAD® QUADRIVALENT, the first and only adjuvanted quadrivalent influenza vaccine, and its importance. It was developed to help protect adults 65 years and older against seasonal influenza.
